Form 8-K - Current report:
SEC Accession No. 0000920148-26-000131
Filing Date
2026-04-09
Accepted
2026-04-09 06:54:28
Documents
13
Period of Report
2026-04-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lh-20260408.htm   iXBRL 8-K 25843
2 EX-99.1 formpr040926ex991dividenda.htm EX-99.1 5677
6 GRAPHIC lc2020logov2a.gif GRAPHIC 4887
  Complete submission text file 0000920148-26-000131.txt   155397

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lh-20260408.xsd EX-101.SCH 2025
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lh-20260408_lab.xml EX-101.LAB 22141
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lh-20260408_pre.xml EX-101.PRE 12587
16 EXTRACTED XBRL INSTANCE DOCUMENT lh-20260408_htm.xml XML 2699
Mailing Address 358 S MAIN ST BURLINGTON NC 27215
Business Address 358 S MAIN ST BURLINGTON NC 27215 3362291127
LABCORP HOLDINGS INC. (Filer) CIK: 0000920148 (see all company filings)

EIN.: 992588107 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-11353 | Film No.: 26849776
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)